Aurora Cannabis (ACB) Times Interest Earned (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Times Interest Earned of $2.26 for Q1 2026, down 90.59% year-on-year from $23.98 in Q1 2025, and down 90.59% on a QoQ basis from $23.98 in Q1 2025.
Aurora Cannabis (ACB) Times Interest Earned (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Times Interest Earned for 9 consecutive years, with $2.26 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned fell 90.59% year-over-year to $2.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.23 (up 357.27% YoY) and the FY2026 annual result came in at -$9.93, down 1083.18% from the prior year.
- Times Interest Earned slipped to $2.26 in Q1 2026 per ACB's latest filing, from $23.98 in the prior quarter.
- Over the last five years, Times Interest Earned for ACB reached as high as $23.98 in Q1 2025 and fell as low as -$29.51 in Q1 2022.
- A 4-year average of $1.14 and a median of -$0.56 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned soared 38.26% — and 2026, when it plunged 90.59%.
- Year by year, Times Interest Earned stood at -$5.77 in 2022, then soared by 423.53% to $18.65 in 2024, then increased by 28.57% to $23.98 in 2025, then tumbled by 90.59% to $2.26 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $2.26, $23.98, and $18.65 for Q1 2026, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 2.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 |
| Mar 31, 2025 | 23.98 |
| Dec 31, 2024 | 18.65 |
| Sep 30, 2024 | -1.10 |
| Jun 30, 2024 | -0.56 |
| Jun 30, 2022 | -5.77 |
| Mar 31, 2022 | -29.51 |
| Dec 31, 2021 | -3.90 |
| Sep 30, 2021 | -2.57 |
| Jun 30, 2021 | -3.16 |
| Mar 31, 2021 | -47.80 |
| Dec 31, 2020 | 315.76 |
| Sep 30, 2020 | -2.89 |
| Jun 30, 2020 | -16.59 |
| Mar 31, 2020 | 12.42 |
| Dec 31, 2019 | 11.20 |
| Sep 30, 2019 | -75.00 |
| Jun 30, 2019 | 144.43 |
| Mar 31, 2019 | 5.55 |
| Dec 31, 2018 | 27.00 |